Breg、PD1、PDL1通过耐受性树突状细胞在实验性自身免疫性脑脊髓炎中的治疗作用及机制
[Abstract]:Research background and purpose: multiple sclerosis (MS) is a chronic inflammatory autoimmune disease of the central nervous system. The main pathological features of the brain and spinal cord destruction and myelin loss are the different severity of the clinical manifestations of.MS patients. The heavy persons can cause physical disability and greatly reduce the quality of life of the patients. Experimental autoimmune encephalomyelitis (experimental autoimmune encephalomyelitis, EAE) is a common animal model in MS basic experimental research. Dendritic cell (DC), as a full-time antigen presenting cell, plays an important role in the pathogenesis of MS. The specific type of DC is of potential therapeutic value for MS by inducing the formation of regulatory T cells (regulatory T cell, Treg) and promoting the secretion of anti inflammatory factors. The programmed death receptor (programmed death 1, PD1) and programmed death ligand 1 (programmed death 1) belong to the superfamily, by playing a negative regulatory role. Regulatory B cell (Breg) is a kind of B cell (regulatory B cell, Breg), which can inhibit the development of the disease by secreting anti inflammatory factors in the pathogenesis of MS, and.1,25 (OH) 2D3 is an immune regulator. The EAE mice of the disease can play a certain therapeutic role. This experimental subject intends to induce mononuclear cells derived from bone marrow in vitro to become DC, and then 1,25 (OH) 2D3 induced by immunoregulation to form VD3-DC, to detect the expression of PDL1 on the surface of normal DC and VD3-DC, and then return normal DC and VD3-DC to the infected EAE mice: (1) observation and transfusion. Changes in clinical symptoms of EAE mice after treatment; (2) detection of the expression of PD1 on the surface of T cells in the spleen and lymph nodes; (3) to detect the proportion of Breg in the spleen and lymph node B cells; (4) the infiltration of inflammatory cells and demyelinating lesions in the spinal cord of the mice were observed by HE and LFB staining. Breg, PD1, PDL1 were investigated by 1,25 (OH). The therapeutic effect and mechanism of the experimental autoimmune encephalomyelitis. Methods: (1) a mixed emulsion of complete freund's adjuvant (CFA) and MOG35-55 was injected into the C57BL/6 mice subcutaneously on the back, and the EAE animal model was established by intraperitoneal injection of pertussis toxin (pertussis toxin, PTX) on the day of immunization and 2 days after the immunization. (2) -4 (interleukin-4, IL-4) and granulocyte macrophage stimulating factor (granulocyte-macrophage colony-stimulating factor, GM-CSF) (10ng/ml) were added to the culture base to induce mononuclear cells from the bone marrow of the femur and tibia to induce DC. induced DC, while adding 1,25 (OH) into the culture base to induce the DC. Lead to VD3-DC. and then add lipopolysaccharide (lipopolysaccharide, LPS) to normal DC and VD3-DC to stimulate 24h, promote its maturation and detect the expression of PDL1 on the surface of DC and VD3-DC by flow cytometry; (3) the EAE mice are divided into three groups. After eighth days of DC/VD3-DC induction, they are incubated with MOG antigen for 4 hours. DC through the tail vein to EAE mice (EAE mice induced day 10,13,16) and observe the changes of clinical symptoms in each group. (4) the spleen and lymph node cells of EAE mice were separated after the return transfusion treatment, and the expression of PD1 and the proportion of Breg on the cell surface were detected by flow cytometry; (5) the peak of the treatment was at the peak. During the period, the spinal cord of mice was separated and the infiltration of inflammatory cells and the loss of myelin sheath in EAE mice were observed by hematoxylin-eosin staining (HE) and lux fast blue staining (Luxol fast blue, LFB). The results of the study were: (1) according to our previous experiments, the same experimental method could be successfully induced. The EAE mouse model and VD3-DC. test showed that the expression of PDL1 on the surface of VD3-DC increased in comparison with the normal DC, and the difference was statistically significant. (2) compared with the PBS control group, DC and VD3-DC could effectively reduce the clinical symptoms of EAE mice, and the effect of VD3-DC was more significant; (3) compared with the PBS control group, The expression of PD1 on the surface of T cells of spleen and lymph node in group VD3-DC and DC group increased and had statistical significance, but there was no significant difference in the expression of PD1 between the VD3-DC group and the normal DC group. (4) the proportion of Breg (CD19+CD5+CD1d+) in the spleen B cells in the VD3-DC group was significantly increased compared with that of the PBS control group, and the proportion of the spleen cells in the normal group was proportional to the proportion of the spleen cells in the normal group. The difference was not statistically significant; at the same time, the proportion of Breg in the lymph node B cells of the VD3-DC group and the normal DC group increased, but the difference was not statistically significant. (5) according to HE and LFB staining, compared with the PBS control group, DC and VD3-DC retransfusion of EAE mice could reduce the infiltration of myeloamedullary cells and the degree of myelinating in the mice, and the VD3-DC action was used. Conclusion: (1) the expression of PDL1 on the surface of VD3-DC cells increased; (2) VD3-DC could effectively reduce its clinical symptoms after EAE transfusion; (3) VD3-DC transfusion could increase the proportion of Breg in the spleen and lymph node B cells in EAE mice and the expression of PD1 of the spleen and lymph node T cell surface; (4) the infiltration of inflammatory cells in the spinal cord could significantly decrease the infiltration of inflammatory cells in the spinal cord. And the degree of loss of myelin sheath.
【学位授予单位】:吉林大学
【学位级别】:硕士
【学位授予年份】:2017
【分类号】:R744.51
【相似文献】
相关期刊论文 前10条
1 李继红,李如琴;树突状细胞的分化发育以及在抗感染中的作用[J];山西临床医药;2001年05期
2 孔令平,刘妍,黄志勤;树突状细胞的特性与分化发育[J];赣南医学院学报;2003年02期
3 赵谨 ,王心;树突状细胞(dendritic cells)[J];日本医学介绍;2005年06期
4 张临友,郭松,杨宝峰;激素与树突状细胞[J];国外医学(移植与血液净化分册);2005年05期
5 吴萍萍;杜晓英;刘书逊;陈荣军;寿张飞;陈江华;;不同来源人树突状细胞的培养诱导及鉴定[J];浙江医学;2007年09期
6 ;封面图片——树突状细胞[J];中国厂矿医学;2009年04期
7 张锦X,陈海滨,谢庆东,王骏;人血树突状细胞形成细胞簇功能的体外观察[J];解剖学杂志;1997年02期
8 曹华,张锐,裴雪涛;树突状细胞的生物学特性及临床应用[J];基础医学与临床;2000年06期
9 王黎明,刘艳荣,李金兰,常艳,付家瑜,高晖,陈珊珊;人慢性粒细胞白血病树突状细胞的培养和鉴定[J];中华医学杂志;2000年05期
10 夏青,张学军;真皮树突状细胞与皮肤病[J];国外医学.皮肤性病学分册;2000年02期
相关会议论文 前10条
1 蒋应明;万涛;陈国友;夏大静;周向阳;修方明;张意;曹雪涛;;树突状细胞来源的钙粘着相关蛋白新基因的克隆、表达及功能研究[A];中国免疫学会第四届学术大会会议议程及论文摘要集[C];2002年
2 王胜军;王丽莉;李坚;许化溪;;肺癌患者胸水中树突状细胞的诱导和初步鉴定[A];中国免疫学会第四届学术大会会议议程及论文摘要集[C];2002年
3 徐克成;牛立志;郭子倩;张德春;左建生;;树突状细胞及其在癌肿治疗中应用[A];中国中西医结合学会第十五次全国消化系统疾病学术研讨会论文汇编[C];2003年
4 何广胜;邵宗鸿;和虹;刘鸿;施白;洁均;曹燕然;Q,
本文编号:2132203
本文链接:https://www.wllwen.com/yixuelunwen/shenjingyixue/2132203.html